DIA Annual Meeting

DIA Annual Meeting

www.diahome.org/DIA2013
Boston, MA / The DIA 2013 49th Annual Meeting: Advancing Therapeutic Innovation and Regulatory Science will be returning to Boston, one of the strongest life sciences region
DIA Annual Meeting
More ideas from DIA Annual Meeting
PAREXEL's Chuck Stevens discusses data requirements of public/private pa...

PAREXEL's Chuck Stevens discusses data requirements of public/private pa.

DIA 2013 49th Annual Meeting Exhibitors - Submit a Press Release | Business Wire

DIA 2013 Annual Meeting Exhibitors - Submit a Press Release

Hamburg: FDA To Tighten Scrutiny Of Diagnostics.

Our story last week about a public hearing on fibromyalgia being planned by the Food and Drug Administration really resonated with National Pain Report readers – so much so that many couldn’t wait …

D-Wise to Attend the DIA 2013 49th Annual Meeting

D-Wise to Attend the DIA 2013 49th Annual Meeting

Verified Clinical Trials At DIA 2013 Stops Dual Enrollment In Clinical Trials And Is Uniquely Positioned To Help You Comply With The Medicare Secondary Payer Act In Clinical Trials

Verified Clinical Trials At DIA 2013 Stops Dual Enrollment In Clinical Trials And Is Uniquely Positioned To Help You Comply With The Medicare Secondary Payer Act In Clinical Trials

Ahsan Jamil shares his first experience at the DIA Marketing Pharmaceuticals Conference 2013.

Ahsan Jamil shares his first experience at the DIA Marketing Pharmaceuticals Conference

Farah Al Kurdi, postodoctoral fellow at the University of Southern California--Allergan, shares her experience at the DIA Marketing Pharmaceuticals Conference 2013.

USC Postdoctoral Fellow Shares Experience at DIA Marketing Pharmaceuticals 2013

Swapu Banerkee, DIA Board Member and Head of Development Consulting at Popewoodhead, describes what topics will be covered during the Module VIII GVP session entitled "The New European Pharmacovigilance Legislation: Guiding Medical Writers Through the Risks and Benefits", which will be held on June 25 from 1:45-3:15 PM at DIA 2013 49th Annual...

Swapu Banerkee, DIA Board Member and Head of Development Consulting at Popewoodhead, describes what topics will be covered during the Module VIII GVP session entitled "The New European Pharmacovigilance Legislation: Guiding Medical Writers Through the Risks and Benefits", which will be held on June 25 from 1:45-3:15 PM at DIA 2013 49th Annual...

Barry A. Berger, JD, MBA, Professor of Regulatory Affairs at Temple University's School of Pharmacy invites you to attend the forum session on "Enforcement Trends and Public Policy: Lessons Learned and Practices to Follow", to be held on Wednesday, June 26 from 10:15 AM-11:45 AM at DIA 2013 49th Annual Meeting. Read more about the session at htt...

Barry A. Berger, JD, MBA, Professor of Regulatory Affairs at Temple University's School of Pharmacy invites you to attend the forum session on "Enforcement T.

Incoming President of the DIA's Board of Directors, Minnie Baylor-Henry, and Ilyssa Levins, DIA-HBA Project Co-chair, invite you to attend preconference tutorial #41, entitled: "DIA-HBA Skill Building Series: A Custom-fit Leadership Approach for Women in Middle Management in the Regulatory, Medical, Legal and Compliance Functions." This leadersh...

Minnie Baylor-Henry and Ilyssa Levins, DIA-HBA Project Co-chairs, invite you to attend preconference tutorial entitled: "DIA-HBA Skill Building Series: .

DIA 2013 49th Annual Meeting - Preliminary Program

DIA 2013 49th Annual Meeting - Preliminary Program

DIA 2013 49th Annual Meeting

DIA 2013 49th Annual Meeting

Navigate Medical and Scientific Communications 2013 from Your Mobile Device!  To download, search for "MSC 2013" in your device's app store.

Navigate Medical and Scientific Communications 2013 from Your Mobile Device! To download, search for "MSC 2013" in your device's app store.